The haemodynamic effects of fazadinium were compared in two groups of elderly patients with class III functional heart failure about to undergo gastrointestinal surgery. Four patients were in sinus rhythm and four in atrial fibrillation. Following the assessment of baseline values fazadinium 1 mg kg"' was injected i.v. and measurements obtained every 1 min for ISmin. In patients in sinus rhythm, fazadininm produced a decrease in total peripheral resistance, which was maximum at the 1st min (ATPRI -738 ±88 dynscm~!m 2 ) and accompanied by a moderate decrease in arterial pressure (MAP -27 ±2.4 mm Hg) and cardiac index (ACI -0.23 ±0.17 litre min" 'm' 1 ) and a moderate increase in heart rate (AHR +16 ±5.7 beat min" 1 ). In patients in atrial fibrillation, a similar decrease in total peripheral resistance (ATPRI -1160 ±174 dyncm~5m z ) was accompanied by a significantly more pronounced tachycardia (AHR +71 ±5.1 beatmin" 1 ) (P<0.001) and decreases in arterial pressure (AMAP -51.7± 5.9mmHg) 0.01) and stroke index (P<0.02).
Tachycardia has been observed consistently in many haemodynamic studies on the non-depolarizing neuromuscular blocker fazadinium. The changes in arterial pressure were more varied, but a transient decrease has been reported in most instances and ascribed, on the basis of experimental studies (Bolger et al., 1972) , to a ganglioplegic effect of the drug. Although changes in cardiac output have been reported these were variable and largely dependent upon changes in heart rate. An increase in cardiac output was noted in patients with normal function (Patschke et al., 1974; Coleman et al., 1975; Lienhart, Tauvent and Guggiari, 1980) , whereas a decrease was observed in patients with coronary disease who were in incipient heart failure (Pinaud et al., 1980) . However, no study of fazadinium has been conducted in patients with overt heart failure. The present study compared the haemodynamic effects of fazadinium in patients with heart failure, considering both patients in sinus rhythm and patients with atrial fibrillation.
PATIENTS AND METHODS

Patients
Eight patients aged from 71 to 82yr with class III functional heart failure (New York Heart Associa- Correspondence to M.P.
tion classification) gave their informed consent. Two groups were studied: patients in sinus rhythm (n = 4; mean age 75.5 ± 3 yr and patients with atrial fibrillation (n = 4; mean age 74.5±3.Syr). All patients were being treated with digoxin 0.25 mg per day orally, frusemide (40-80 mg per day orally)and heparin (5000 i.u. subcutaneously thrice daily). All were about to undergo surgery of the stomach, large bowel or biliary tract and were investigated immediately before the operation.
Anaesthetic procedure
No premedication was given. The pharynx, glottis and trachea were thoroughly sprayed with 5% lignocaine and 15 min later, anaesthesia was induced with 1% methohexitone 1.5mgkg~' i.v. Tracheal intubation was smooth and unattended by coughing. Intermittent positive pressure ventilation was commenced (RPR Pesty Technomed), (oxygen: nitrous oxide, 1:3) and adjusted to maintain P&co 2 between 3.9 and 4.5kPa. fto 2 was maintained between 16 and 18kPa. Baseline haemodynamic values were determined as described below and 10 min later fazadinium lmgkg" 1 was injected i.v. No manipulations were undertaken while the 15-min haemodynamic study was performed. When it was completed methohexitone, fentanyl and fazadinium were given as required and the operation started.
Haemodynamic study
Heart rate (HR) was monitored from a continuous recording of the ECG (V 5 lead) (EKG Amplifier 830, © The Macmillan Press Ltd 1983 Siemens Elema). Shortly before induction, two catheters were inserted under local anaesthesia: a 7F balloon thermodilution catheter was passed, under x-ray control, into the pulmonary artery and a 4F catheter placed in the radial artery, thus allowing the simultaneous measurement of pulmonary wedge pressure (PWP), systolic arterial pressure (SAP) and diastolic arterial pressure (DAP) (Pressure Transducer 766, Pressure Amplifier 863, SiemensElema). Values were recorded on a polygraphic recorder (Mingograph 803, Siemens-Elema). Cardiac output (CO) was measured using the thermodilution method. Mean arterial pressure (MAP), cardiac index (CI), stroke index (SI) and total peripheral resistance index (TPRI) were calculated from the data obtained: MAP = (SAP -DAP)/3 + DAP; CI = CO/ body surface area; SI = CI/HR; TPRI = (MAP x 80)/CI.
All measurements were obtained before the induction of general anaesthesia, 10 min after induction (baseline values), and then every 1 min during the 15 min following injection of fazadinium i.v.
Statistical analysis
Differences in mean haemodynamic values between the sinus rhythm and atrial fibrillation groups were analysed using Student's t test for unpaired data. The paired test was used to analyse the differences between baseline values and post-fazadinium values within each group. T.inpnr correlations were calculated by the method of least squares.
RESULTS
Before the study the two groups of patients were comparable as regards plasma concentrations of digoxin, sodium and potassium. Pao 2 anĥ aemodynamic values were similar also, the latter reflecting heart failure (table I).
Haemodynamic changes induced by fazadinium in
patients with sinus rhythm (table II) The effects of fazadinium on HR, SAP, DAP, MAP and TPRI were maximum during the first 2 min following the injection. Then, there was a progressive return to pre-treatment values which was correlated with time: HR (r= 0.95; P<0.001); SAP (r = 0.89; P<0.001); DAP (r = 0.97; P<0.001); MAP (r=0.95; P<0.001); TPRI (r = 0.88; P<0.001). By 15min the only significant changes were decreases (P<0.05) in SAP, MAP and PWP. Changes in MAP correlated with changes in HR (r= 0.94; P<0.001); SI (r= 0.52; P<0.05) and TPRI (r = 0.80; P<0.001).
Changes in CI and SI were maximum and significant (P <0.05) at about 10 min, but were not related to time (r = 0.32). Changes in CI correlated with changes in TPRI(r = 0.67; P<0.01). Changes in SI correlated with changes in PWP (r=0.64; P<0.02), but not with changes in HR (r = 0.48).
Haemodynamic changes induced by fazadinium in patients with atrial fibrillation (table III) All the indices were altered significantly, with the maximum effects within 2 or 3 min from the time of injection. There was a sharp increase in HR (P < 0.001), marked decreases in SAP (P< 0.001), DAP (P<0.01), MAP (P<0.001), CI (P<0.01), SI (P<0.001) and TPRI (P<0.01) and a decrease in PWP (P< 0.01). These changes were followed by a slow return to pretreatment values with time. At 15 min, the return was complete for all indices except CI, which remained significantly decreased (P<0.05).
The changes in MAP correlated with changes in HR (r= 0.95), CI (r= 0.94), SI(r= 0.96) and TPRI (r = 0.99). The changes in CI correlated with (table IV) The decreases in PWP, CI and TPRI were comparable in both groups. Tachycardia was more pronounced (P< 0.001), and the decreases in SAP (P<0.001), DAP(P<0.05), MAP(P<0.01)and n.s. SI (P < 0.02) more significant in patients with atrial fibrillation than in patients in sinus rhythm.
Comparison of maximum haemodynamic changes in the two groups of patients
DISCUSSION
In patients with normal cardiac function faxadinium induced a tachycardia and a moderate increase in cardiac index (Patschke et al., 1974; Coleman et al., 1975) which compensated for the decrease in total peripheral resistance. As a result, the arterial pressure remained unchanged. A more recent and selective haemodynamic study (Lienhart, Tauvent and Guggiarij 1980) provided evidence in favour of the vagolytic and gangiioplegic effects of fazadinium. The injection i.v. of 1 mg kg" 1 over 30 s to patients with head injury undergoing artificial ventilation resulted in a 28% decrease in arterial pressure lasting less than 5 min, an increase in cardiac output during the 1st min and a 31% decrease in peripheral resistance which lasted for 5 min. The increase in heart rate (29%) persisted for 60 min.
In another study, involving patients with chronic ischaemic heart disease who were in incipient heart failure (Pinaud et al., 1980) , haemodynamic measurements were started 5 min after an injection of fazadinium. The small and non-significant changes recorded were maximum 10 min after the injection. They consisted of tachycardia and decreases in arterial pressure and cardiac index.
In the present study, fazadinium administered to patients in heart failure and in sinus rhythm induced a decrease in peripheral resistance which was most marked within a few minutes and resulted in a decrease in mean arterial pressure and an increase in heart rate. The drug also decreased the puhnonary wedge pressure with a subsequent decrease in stroke index. Despite the tachycardia, the cardiac index was decreased. These changes were moderate and all values returned progressively to normal.
In patients in heart failure with atrial fibrillation fazadinium produced qualitatively similar changes in peripheral resistance, mean arterial pressure, heart rate and puhnonary wedge pressure, with subsequent decreases in stroke index and cardiac index. However, some of these changes were much more pronounced and the return to baseline values was slower. While the decrease in total peripheral resistance was about the same in both groups, as could be expected in view of the gangiioplegic effects of fazadinium, the tachycardia was more marked, reaching 170 beat min" 1 on average (up to 190 beat min" 1 in one patient), as opposed to 105 beat min" 1 in patients in sinus rhythm (P< 0.001). Similarly, the stroke index decreased to ll^mlbeat^m-2 as against 18.7 ml beat" 1 m" 2 (P<0.02) and the mean arterial pressure to 46.2mmHg compared with 69.5mmHg in the group in sinus rhythm (P< 0.01). These findings are consistent with the precarious haemodynamic status of patients with atrial fibrillation. Whether the effects observed are specific to fazadinium is impossible to say, since no haemodynamic study of other neuromuscular blockers has been conducted in such patients.
